Sanofi Announces Launch of Verorab® (Sanofi Inactivated Rabies Vaccine) in the UK for Pre-exposure and Post-exposure Prophylaxis of Rabies in All Age Groups

Contributed by: Business Wire

Logo

Tags

Research

Other Health

Pharmaceutical

Vacation

Other Travel

Infectious Diseases

Destinations

Travel

Clinical Trials

Science

Biotechnology

Health

Other Science

Sanofi

More Like This

Rabies case confirmed following contact with animal abroad

PR Newswire associated0

Novavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.

ViiV Healthcare data show 89% of treatment-naïve people with HIV choose to switch to long-acting injectable Vocabria + Rekambys from daily pills after achieving rapid viral suppression

ViiV Healthcare presents new data demonstrating positive real-world impact of its innovative long-acting injectables for HIV at IAS 2025

ViiV Healthcare to present data for its next generation of ultra long-acting treatments for HIV

MHRA approves Comirnaty JN.1 COVID-19 vaccine for adults and children from infancy

ViiV Healthcare expands on real-world data supporting use of long-acting therapies in diverse patient populations at HIV Glasgow

ViiV Healthcare extends voluntary licensing agreement with Medicines Patent Pool to enable access to innovative long-acting injectable HIV treatment